Facebook appears to be in a back-and-forth with big pharmaceutical companies that do not wish to let users comment on their pages.
Multiple companies are claiming that Facebook is requesting that all pages enable users to comment on the page.
According to an article quoted by Tracy Staton, Facebook stated that it’s an overall policy change. Specifically, “We think these policy changes support consistency for the Facebook pages product and encourage an authentic dialogue between people and businesses on Facebook.”
Apparently, though, brand pages are still allowed to block comments from users but drug makers cannot. Given the massive amounts of funding that pharmaceutical companies have for communications and marketing, this is generating a substantial amount of controversy. While it’s clear that there’s some debate going on between Facebook and the pharma companies, it’s not yet clear how this will pan out.
In the meantime, companies like Hearsay Social will be big winners of this type of policy as they enable large organizations to monitor all comments even in highly regulated environments. We’ve reached out to Facebook for clarifications on this policy and will update this post if we hear back.